“Functional Equivalence” Battle Has Just Begun, Sen. Hatch Aide Says
Executive Summary
Reimbursement for biologics will come under increased scrutiny with the passage of a Medicare drug benefit, Sen. Orrin Hatch's Legislative Assistant Bruce Artim predicts
You may also be interested in...
Medicare Bills Head To Conference: Senate Earns Broader Bipartisan Support
The Senate Medicare prescription drug bill is heading to conference with greater bipartisan support than its counterpart in the House
CMS “Functional Equivalence” Standard Targeted In Medicare Bills
CMS would be prohibited from using the Aranesp/ Procrit "functional equivalence" decision as a precedent in future reimbursement rulings under both the House and Senate versions of the Medicare prescription drug bill
Aranesp Fallout: Managed Care May Follow CMS In “Functional Equivalence”
Managed care organizations may start using functional equivalence as a tool in determining coverage levels, biotech companies agreed during a panel presentation at the Kellogg Biotech Conference in Chicago April 5